Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?

NCT02416570 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT02416570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02416570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?
Lead sponsor
University of Nottingham
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2015
Completion date
October 31, 2015
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, lung cancer